Stephane Navé - Concepedia

Author

Stephane Navé

Roche (Switzerland)

Also Known As

STEPHANE NAVE, Stephane Nave, Stephane Navé

Publications

540

Citations

H-Index

Concepts

All Affiliations

Roche (Switzerland)Roche (France)Roche (United Kingdom)Hôpitaux Universitaires de Strasbourg AbbVie (United States)

About

Stephane Navé is an author at Roche (Switzerland) specializing in medicine, gynecologic surgery, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	113
2	Anesthesia	1	1	29
3	Gastroenterology	1	1	29
4	Neurology	1	1	84
5	Neuroscience	1	1	84

Stephane Navé

Publications

502

Citations

H-Index

Page 1

	Year	Citations
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA <i>In Silico</i> Strategy Zhihua Li, Gary R. Mirams, Takashi Yoshinaga, Clinical Pharmacology & Therapeutics	2019	106
Contingent negative variation as a dopaminergic biomarker: evidence from dose-related effects of methylphenidate A.M.W. Linssen, Eric Vuurman, Anke Sambeth, Psychopharmacology	2011	86
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease Edilio Borroni, Bernd Bohrmann, Fiona Grueninger, Journal of Pharmacology and Experimental Therapeutics PharmacotherapyAlzheimer ’Oxidative StressMolecular PharmacologyAlzheimer's Disease	2017	84
Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD) Stephane Navé, Rachelle S. Doody, Merçé Boada, Journal of Alzheimer s Disease	2017	46
Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man Joerg F. Hipp, Frédéric Knoflach, Robert A. Comley, Scientific Reports	2021	35
Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy Robert C. Sergott, Giulia Maria Amorelli, Giovanni Baranello, Annals of Clinical and Translational Neurology	2020	34
The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects Cornelia Weber, Ludger Banken, Herbert Birnboeck, British Journal of Clinical Pharmacology	1999	29
Intravenous dolasetron mesilate in the prevention of postoperative nausea and vomiting in females undergoing gynecological surgery Pierre Diemunsch, Alain D’Hollander, Lionel Paxton, Journal of Clinical Anesthesia Gynecologic SurgeryGynecological SurgeryGastroenterologyGynecologyIntravenous Dolasetron Mesilate	1997	29
Oral Dolasetron Mesylate for Prevention of Postoperative Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Study Staff Anesthesiolog Pierre Diemunsch, Kari Korttila, Jos Leeser, Journal of Clinical Anesthesia	1998	28
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline Stefan Sturm, Anton Forsberg, Stephane Navé, European Journal of Nuclear Medicine and Molecular Imaging	2016	25

Page 1